Advertisement

Topics

Sills Cummis Epstein & Gross P.C. Company Profile

21:31 EST 19th January 2019 | BioPortfolio

Founded in 1971, Sills Cummis has established an outstanding global reputation. Our growth has been made possible by a large national client roster and an ever-expanding list of international client corporations. The Firm was featured in Chambers USA Guide to America's Leading Lawyers for Business which ranked the Real Estate Department first in New Jersey and the Corporate, Employment and Labor, and Litigation Departments in the top three in the State. Our growth continues because Sills Cummis Epstein & Gross P.C. is more than just a law firm. It is a think tank for the industries that choose us. We go beyond what is expected of a law firm by partnering with our clients and taking an insider’s view of each client’s business.On a national level, our lawyers represent companies from Fortune 500 to emerging growth. On an international level, we are frequently called upon and have been focusing on cross-border transactions with non-U.S. companies doing business in the U.S. As a full-service firm, our clients have access to all of our practice groups, thus alleviating the need to bring in other consultants when ancillary issues arise

Location

The Legal CenterOne Riverfront Plaza
Newark
New Jersey
07102
United States of America

Contact

Phone: (973) 643-7000
Fax: (973) 643-6500


News Articles [100 Associated News Articles listed on BioPortfolio]

Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma

Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today present...

Schizophrenia linked with abnormal immune response to Epstein-Barr virus

(Johns Hopkins Medicine) New research from Johns Hopkins Medicine and Sheppard Pratt Health System shows that people in the study with schizophrenia also have higher levels of antibodies against the E...

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Tokyo Medical and Dental University study shows that ruxolitinib-induced inhibition of STAT3 activity blocks survival and reduces pro-inflammatory cytokine production in Epstein-Barr virus (EBV)-infec...

VIDEO | Mohawk's Royce Epstein Shares Her Personal Experience with Breast Cancer

SOURCE: Mohawk Industries DESCRIPTION:In 2014, Royce Epstein received life-changing news after having a routine mammogram — she had breast cancer. Four years later, the Mohawk Group A&D Directo...

After Blockbuster Maiden Lithium Resource, How Will PEA Look?

Peter Epstein of Epstein Research speaks with the CEO of a lithium explorer that plans to release a PEA on its Nevada project soon. Investors rely on us to share promising investment ideas in a chang...

Wealth Minerals Prudently, Albeit Slowly, Advancing in Chile

Peter Epstein of Epstein Research discusses whether the lithium market is oversold and profiles one lithium company that he follows. Investors rely on us to share promising investment ideas in a chan...

$ATRA Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS) #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667575/0/en/Atara-Biotherapeutics-Presents-Positive-Efficacy-and-Safet

$ATRA Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS) #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667575/0/en/...

The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis

Drugs and Medications [55 Associated Drugs and Medications listed on BioPortfolio]

Air [Scott-Gross Company, Inc.]

Air Label

Romidepsin [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use ROMIDEPSIN safely and effectively.  See full prescribing information for ROMIDEPSIN. ROMIDEPSIN for injection, for intravenous use In...

Romidepsin [Teva Parenteral Medicines, Inc.]

These highlights do not include all the information needed to use ROMIDEPSIN safely and effectively.See full prescribing information for ROMIDEPSIN. ROMIDEPSIN for Injection, for intravenous useInitia...

Nitrous oxide [Scott-Gross Company, Inc.]

Nitrous Oxide

Glucotrol [Roerig]

Glucotrol XL

PubMed Articles [236 Associated PubMed Articles listed on BioPortfolio]

Difference in physical fitness in children with initially high and low gross motor competence: A ten-year follow-up study.

The aim of the study was to investigate the difference in relative physical fitness between children with initially high and low gross motor competence in a ten-year prospective study. A sample of 49 ...

Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus.

Epstein-Barr virus (EBV) is a highly prevalent human herpesvirus capable of infecting the central nervous system and establishing persistent infection.

Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.

The prognosis of patients who have Epstein-Barr virus (EBV)-related nasopharyngeal carcinoma (NPC) in which the tumor tissues harbor EBV have a better prognosis than those without EBV-related NPC. The...

Epstein-Barr Virus Hepatitis: A Review of Clinicopathologic Features and Differential Diagnosis.

The liver is frequently affected by Epstein-Barr virus (EBV) infection, but involvement is commonly subclinical and self-limited. Severe and potentially fatal EBV hepatitis has also been occasionally ...

Psychometric properties of gross motor assessment tools for children: a systematic review.

Gross motor assessment tools have a critical role in identifying, diagnosing and evaluating motor difficulties in childhood. The objective of this review was to systematically evaluate the psychometri...

Clinical Trials [229 Associated Clinical Trials listed on BioPortfolio]

Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants

RATIONALE: Donor lymphocytes that have been exposed to Epstein-Barr virus may be able to help the body kill cancers associated with this virus. PURPOSE: Phase I trial to study the effecti...

Immunodeficiency for Severe Epstein-Barr Virus Infection

The purpose of this study is to investigate the immune responses associated with Epstein-Barr virus infections, and to find out the possible immunodeficiencies that may be linked to severe...

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

RATIONALE: The Epstein-Barr virus can cause cancer and lymphoproliferative disorders. Valganciclovir is an antiviral drug that acts against the Epstein-Barr virus. Phenylbutyrate may make ...

Biological Therapy in Treating Patients With Lymphoma, Lymphoproliferative Disease, or Malignancies

RATIONALE: Some types of lymphoma or lymphoproliferative disease are associated with Epstein-Barr virus. White blood cells from donors who are immune to Epstein-Barr virus may be an effect...

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

RATIONALE: Peripheral blood lymphocyte therapy may be effective in the treatment and prevention of Epstein-Barr virus infection following transplantation. PURPOSE: Phase II trial to study...

Companies [35 Associated Companies listed on BioPortfolio]

Sills Cummis Epstein & Gross P.C.

Founded in 1971, Sills Cummis has established an outstanding global reputation. Our growth has been made possible by a large national client roster and an ever-expanding list of international client c...

Epstein Becker Green

Epstein Becker & Green, P.C., is a national law firm with a primary focus on health care and life sciences; employment, labor, and workforce management; and litigation and busines...

Jason Epstein

Pomerantz Haudek Grossman & Gross LLP

NRG Renew LLC

NRG Renew, a subsidiary of NRG Energy, Inc., owns or has partial investment in more than 150 renewable energy projects totaling approximately 4,500 gross MWac of solar and wind ca...

More Information about "Sills Cummis Epstein & Gross P.C." on BioPortfolio

We have published hundreds of Sills Cummis Epstein & Gross P.C. news stories on BioPortfolio along with dozens of Sills Cummis Epstein & Gross P.C. Clinical Trials and PubMed Articles about Sills Cummis Epstein & Gross P.C. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sills Cummis Epstein & Gross P.C. Companies in our database. You can also find out about relevant Sills Cummis Epstein & Gross P.C. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record